Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First
Anagha Deshpande,1 Javier Munoz2 1Mayo Clinic Alix School of Medicine, Scottsdale, AZ, USA; 2Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USACorrespondence: Anagha Deshpande, Mayo Clinic Alix School of Medicine, 13400 E Shea Blvd, Scottsdale, AZ, 85259, USA, Tel +1 480 251-0289, Em...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-06-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/zanubrutinib-in-treating-waldenstrm-macroglobulinemia-the-last-shall-b-peer-reviewed-fulltext-article-TCRM |